share_log

Canaccord Genuity Maintains Buy on Aspen Aerogels, Raises Price Target to $28

Canaccord Genuity Maintains Buy on Aspen Aerogels, Raises Price Target to $28

Canaccord Genuity維持對Aspen Aerogels的買入,將目標股價上調至28美元
Benzinga ·  05/03 17:16

Canaccord Genuity analyst George Gianarikas maintains Aspen Aerogels (NYSE:ASPN) with a Buy and raises the price target from $18 to $28.

Canaccord Genuity分析師喬治·賈納裏卡斯維持Aspen Aerogels(紐約證券交易所代碼:ASPN)的買入並將目標股價從18美元上調至28美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論